Investing in Health Care

A senior investment analyst discusses the outlook for investing in health care, focusing on opportunities and challenges. Insights include trends in healthcare investments, tech influence on drug development, and the FDA's adaptive approaches. Challenges post-COVID include competitive landscapes, delays in drug development, and the impact of political interventions. The podcast also explores the evolution and impact of obesity drugs on weight loss and glycemic control, highlighting ozempic's benefits and recent studies on patient outcomes.